間質幹細胞市場規模、佔有率及成長分析（按產品、來源、適應症、應用及地區分類）－產業預測，2025-2032年

預計到 2023 年，全球間質幹細胞市場規模將達到 36 億美元，到 2024 年將成長至 40.5 億美元，到 2032 年將成長至 104.7 億美元，在預測期（2025-2032 年）內，複合年成長率為 12.6%。

間質幹細胞（MSCs）的全球市場正經歷顯著成長，這主要得益於其在再生醫學、組織工程和免疫調節領域公認的治療潛力。 MSCs對組織修復和再生至關重要，並具有分化成多種細胞類型的能力，包括骨細胞、軟骨細胞和脂肪細胞。慢性疾病的增加、細胞療法需求的成長以及MSCs在整形外科、神經科、腫瘤科和皮膚科等廣泛領域的治療應用不斷擴展，共同推動了這一市場擴張。幹細胞庫和生物製程技術的進步，以及生物技術公司、研究機構和醫療機構之間的合作，正在促進臨床試驗的核准。然而，持續的創新和市場發展需要解決倫理問題和監管的複雜性。

全球間質幹細胞市場促進因素

包括心血管疾病、骨關節炎、自體免疫疾病和神經系統疾病在內的慢性疾病發生率不斷上升，正顯著推動全球間質幹細胞市場的成長。間質幹細胞（MSCs）具有卓越的組織再生能力和免疫調節能力，使其成為治療這些疾病的一種極具前景的選擇。隨著越來越多的患者尋求創新的再生療法，基於MSCs的治療方法需求預計將顯著成長，這反映出人們不斷追求有效治療各種慢性疾病的方案。這種對先進治療方法日益成長的需求有望進一步推動MSC領域的發展和投資。

限制全球間質幹細胞市場的因素

全球間間質幹細胞市場面臨許多限制因素，主要源自於研發和治療治療方法高成本。間質幹細胞的生產過程需要專業的實驗室、無塵室環境、先進的設備和訓練有素的人員，以確保細胞的活力、純度和無菌性。此外，細胞分離、擴增和冷凍保存等步驟耗時且耗力。這些因素導致治療費用居高不下，造成患者經濟負擔，尤其是在缺乏健保體系的發展中地區。因此，儘管間質幹細胞治療方法具有顯著的治療優勢，但其推廣應用仍可能受到阻礙。

全球間質幹細胞市場趨勢

全球間間質幹細胞(MSC) 市場正呈現出向再生醫學和個人化醫療發展的明顯趨勢，這主要得益於 MSC 修復和再生受損組織的卓越潛力。這種轉變在肌肉骨骼疾病、心血管疾病、神經系統疾病和自體免疫疾病的治療中尤其顯著，基於 MSC 的治療方法正日益受到醫療機構的青睞。對細胞特性的深入研究、分離技術的改進以及可擴展生產過程的建立，正為更精準的治療方法鋪平道路。此外，預測模型和人工智慧在患者選擇和治療方案製定中的日益普及，正在最佳化 MSC 的應用，有望帶來更好的臨床療效並最大限度地減少副作用。這凸顯了市場對個人化治療方案日益成長的需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球間質幹細胞市場規模（依產品分類）、複合年成長率（2025-2032 年）

• 市場概覽
• 細胞和細胞株
• 套件、培養基和試劑
• 其他

全球間質幹細胞市場規模（依來源分類）、複合年成長率（2025-2032 年）

• 市場概覽
• 骨髓間質幹細胞
• 脂肪組織來源的間質幹細胞
• 臍帶/胎盤來源的間質幹細胞
• 其他

全球間質幹細胞市場規模（依適應症分類）、複合年成長率（2025-2032 年）

• 市場概覽
• 骨/軟骨修復
• 心血管疾病
• 發炎/免疫性疾病
• 肝病
• 癌症
• 移植物抗宿主疾病（GvHD）及其他適應症

全球間質幹細胞市場規模（按應用領域分類），複合年成長率（2025-2032 年）

• 市場概覽
• 疾病模型
• 藥物發現與開發
• 幹細胞庫
• 組織工程
• 毒理學研究

全球間質幹細胞市場規模（按地區分類）、複合年成長率（2025-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Inc.
• Merck KGaA
• Lonza Group Ltd.
• Cyagen Biosciences Inc.
• PromoCell GmbH
• Axol Bioscience Ltd.
• Cellcolabs Clinical Ltd.
• Cell Applications Inc.
• Mesoblast Ltd.
• Cynata Therapeutics
• Orgenesis Inc.
• Stempeutics Research Pvt. Ltd.
• BioRestorative Therapies
• ScienCell Research Laboratories Inc.
• Takara Bio Inc.
• Takara Bio Inc.
• BioTime Inc.
• PLURI Inc.
• Cell Tech Pharmed

結論與建議

Global Mesenchymal Stem Cells Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 10.47 billion by 2032, growing at a CAGR of 12.6% during the forecast period (2025-2032).

The global market for mesenchymal stem cells (MSCs) is witnessing significant growth, fueled by their recognized therapeutic potential in regenerative medicine, tissue engineering, and immunomodulation. MSCs are pivotal for tissue repair and regeneration, with the ability to differentiate into various cell types such as bone, cartilage, and fat. This market expansion is driven by the rising incidence of chronic diseases, increased demand for cell-based therapies, and the broadening applications of MSC treatments across fields like orthopedics, neurology, oncology, and dermatology. Technological advancements in stem cell banking and bioprocessing, alongside collaborative efforts among biotechnology firms, research institutions, and healthcare providers, are enhancing clinical trial approvals. However, challenges such as ethical issues and regulatory complexities must be addressed for sustained innovation and market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mesenchymal Stem Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mesenchymal Stem Cells Market Segments Analysis

Global Mesenchymal Stem Cells Market is segmented by Product, Source, Indication, Application and region. Based on Product, the market is segmented into Cells & Cell Lines, Kits, Media & Reagents and Others. Based on Source, the market is segmented into Bone Marrow-derived MSCs, Adipose Tissue-derived MSCs, Umbilical Cord / Placental MSCs and Others. Based on Indication, the market is segmented into Bone & Cartilage Repair, Cardiovascular Diseases, Inflammatory & Immunological Diseases, Liver Diseases, Cancer and GvHD & Other Indications. Based on Application, the market is segmented into Disease Modeling, Drug Discovery & Development, Stem Cell Banking, Tissue Engineering and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mesenchymal Stem Cells Market

The increasing occurrence of chronic conditions, including cardiovascular issues, osteoarthritis, autoimmune disorders, and neurological diseases, significantly fuels growth in the Global Mesenchymal Stem Cells market. Mesenchymal stem cells (MSCs) possess the remarkable ability to regenerate damaged tissues and modulate immune responses, positioning them as a promising therapeutic alternative for these conditions. As more individuals seek innovative regenerative treatment options, the demand for MSC-based therapies is expected to rise substantially, reflecting the ongoing pursuit of effective solutions for managing various chronic ailments. This escalating need for advanced therapies will likely catalyze further advancements and investments in the MSC sector.

Restraints in the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells market faces significant constraints primarily due to the high costs associated with therapy development and administration. The process of manufacturing mesenchymal stem cells requires specialized laboratories, cleanroom environments, advanced equipment, and a highly trained workforce to ensure the viability, purity, and sterility of the cells. Additionally, the procedures involved in cell isolation, expansion, and cryopreservation are both time-consuming and resource-intensive. These factors contribute to elevated treatment costs, which can pose challenges for patients, particularly in developing regions lacking reimbursement options. Consequently, the adoption of MSC-based therapies, despite their notable therapeutic advantages, can be hindered.

Market Trends of the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells (MSC) market is witnessing a pronounced trend towards regenerative and personalized medicine, driven by the remarkable potential of MSCs to repair and regenerate damaged tissues. This shift is particularly evident in the treatment of musculoskeletal disorders, cardiovascular diseases, neurological problems, and autoimmune disorders, as MSC-based therapies gain traction among healthcare providers. Enhanced research into cellular characteristics, improved isolation methods, and scalable manufacturing processes are paving the way for more precision-focused therapies. Moreover, the integration of predictive modeling and artificial intelligence into patient selection and therapeutic planning is refining MSC applications, promising superior clinical outcomes and minimizing side effects, thereby underscoring a growing preference for individualized treatment approaches within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mesenchymal Stem Cells Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cells & Cell Lines
• Kits, Media & Reagents
• Others

Global Mesenchymal Stem Cells Market Size by Source & CAGR (2025-2032)

• Market Overview
• Bone Marrow-derived MSCs
• Adipose Tissue-derived MSCs
• Umbilical Cord / Placental MSCs
• Others

Global Mesenchymal Stem Cells Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Bone & Cartilage Repair
• Cardiovascular Diseases
• Inflammatory & Immunological Diseases
• Liver Diseases
• Cancer
• GvHD & Other Indications

Global Mesenchymal Stem Cells Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Modeling
• Drug Discovery & Development
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Global Mesenchymal Stem Cells Market Size & CAGR (2025-2032)

• North America (Product, Source, Indication, Application)
  • US
  • Canada
• Europe (Product, Source, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Source, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Source, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Source, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellcolabs Clinical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orgenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRestorative Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PLURI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Tech Pharmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations